IceCure Medical Ltd (ICCM) investor relations documents from the company's IR site: 1 presentation, 11 press releases; latest deck 2026-07-05. Read in-app with summaries. First-party data.
Company Presentation — IceCure Medical (Nasdaq: ICCM) provides the ProSense cryoablation system, the only FDA-authorized minimally invasive device for local treatment of low-risk breast cancer.
ICCM overview · ICCM earnings · ICCM financials · ICCM KPIs · ICCM ownership · ICCM peers · ICCM filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.